SG Americas Securities
ORGS

SG Americas Securities’s Orgenesis Inc. Common Stock ORGS Stock Holding History

SG Americas Securities’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,399
Closed -$324K – 3922
2021
Q2 		$324K Buy
+6,399
New +$322K ﹤0.01% 2132

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

SG Americas Securities's ORGS Position: Q3 2021 in Review

SG Americas Securities sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2021, closing a stake of 6,399 shares — an estimated $324K sold.

SG Americas Securities first reported a position in ORGS in Q2 2021 and held it in 1 quarter. The position peaked at $324K in Q2 2021. 26 funds tracked by Wall St. Rank hold ORGS as of Q3 2021.

  • SG Americas Securities reported no remaining Orgenesis Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • SG Americas Securities sold 6,399 Orgenesis Inc. Common Stock shares in Q3 2021, an estimated $324K.
  • SG Americas Securities first reported a position in Orgenesis Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • SG Americas Securities's Orgenesis Inc. Common Stock position peaked at $324K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2021.

Based on SG Americas Securities's 13F filing for Q3 2021, filed 1 Nov 2021.